HG-1114

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHG-1114
Drug Alias NameG protein coupled receptor 65 modulator (Human Genome Sciences)G-protein receptor HTNAD29 modulator (Human Genome Sciences)Orhpan G protein coupled receptor 1 modulator (Human Genome Sciences)T-cell death associated gene 8 modulator (Human Genome Sciences)TDAG8 modulator (Human Genome Sciences) +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 65 modulators
TargetsG-protein coupled receptor 65
Therapy Area/IndicationsImmune System DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A